Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
about
Neuroimaging of Parkinson's disease: Expanding views.The role of biomarkers and imaging in Parkinson's disease.Neuroimaging in pre-motor Parkinson's diseaseBrain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Neuromelanin in parkinsonian disorders: an update.Neuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseT2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.Bayesian framework inspired no-reference region-of-interest quality measure for brain MRI images.Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.Magnetic resonance imaging for the diagnosis of Parkinson's disease.Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of ParkinsonismLocus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease
P2860
Q28387732-C014D828-45ED-4281-BF94-116C5876B995Q31041660-E1E4523E-EF23-40F6-9D53-20235513BC7AQ33676222-9FB9F189-F5E9-4D9E-B406-8EFF7DDB994EQ33831798-06AFC1AB-8DB3-4FB5-B3B6-4DE14CB4CEA1Q34554452-7AD8274D-FB74-49DB-8D19-AFEB0C2A3833Q36332532-8558CCDC-7275-47AB-AB57-09BCF13E7663Q36359956-C7A4F82F-C0AF-4255-BACD-A0099A326265Q37192855-D08B4ED2-EEEE-429E-95C4-F7002CC7724AQ37396921-870EB0C8-49C2-4090-9E3B-1A5C524301ACQ38718160-53D5D240-9240-4B17-A05E-FD8A0AF2C758Q39119095-E439F4D1-4433-4A61-ABD4-931BE7569EF8Q39220904-0DA5B2F1-3139-49BE-83CE-AFE63ABB7678Q39877122-DE9C3BBD-D09A-43C9-A835-F5DABE877357Q46155272-08F83FEC-15B9-4BCB-AD94-858DDF01EB9CQ46354756-970A7BD0-62AC-4CFF-8259-CD2F0F9E09ACQ47183452-17FD4AB2-1282-4436-A33A-C6344B07FEADQ47653671-0F66F451-EEFB-4CD9-8059-E4A0B07FC29FQ47674599-2BE14A49-4AF8-4475-9776-6A33ADC13BCDQ47680043-A8E417FE-BDD3-4A8A-B02D-C52C4D47D456Q48129184-009CD214-37FC-410D-A30A-79001B2D51F3Q52592689-C91C4A68-C4E3-41DD-BD5B-8CC763E31E37Q55004525-7EB2F9CC-70B8-493F-9FE7-7F6AF90D6744Q58576300-4D29A548-9208-481B-80AF-38B74F7D22A1Q58771356-3AE0B696-3AAA-4C06-AE25-494AD69E42B3
P2860
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@en
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@nl
type
label
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@en
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@nl
prefLabel
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@en
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease
@en
P2093
Arrate Muñoz-Barrutia
Elena Lorenzo
Jaione Irigoyen
Javier Uranga
Marc Puigvert
Marta Vidorreta
María A Pastor
Pau Pastor
Sara Ortega-Cubero
P2860
P304
P356
10.1002/MDS.26201
P407
P577
2015-03-15T00:00:00Z